Your browser doesn't support javascript.
loading
Pharmacogenomic Analysis Reveals CCNA2 as a Predictive Biomarker of Sensitivity to Polo-Like Kinase I Inhibitor in Gastric Cancer.
Lee, Yunji; Lee, Chae Eun; Oh, Sejin; Kim, Hakhyun; Lee, Jooyoung; Kim, Sang Bum; Kim, Hyun Seok.
Afiliação
  • Lee Y; Severance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Lee CE; Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Oh S; Department of Medicine, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Kim H; Severance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Lee J; Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Kim SB; Severance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Kim HS; Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul 03722, Korea.
Cancers (Basel) ; 12(6)2020 May 30.
Article em En | MEDLINE | ID: mdl-32486290
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article